Enanta Pharmaceuticals, Inc. (ENTA)
10.71
-0.44
(-3.95%)
USD |
NASDAQ |
Oct 30, 16:00
10.76
+0.06
(+0.51%)
After-Hours: 20:00
Enanta Pharmaceuticals Price : 10.71 for Oct. 30, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | 11.08 | 11.10 | 10.69 | 10.71 | 202339.0 |
| Oct 29, 2026 | 11.65 | 11.74 | 10.76 | 11.15 | 218488.0 |
| Oct 28, 2026 | 11.20 | 11.77 | 10.70 | 11.55 | 282003.0 |
| Oct 27, 2026 | 11.98 | 12.40 | 11.86 | 12.18 | 319429.0 |
| Oct 26, 2026 | 11.73 | 12.06 | 11.65 | 12.00 | 440615.0 |
| Oct 23, 2026 | 11.57 | 11.68 | 10.97 | 11.64 | 228231.0 |
| Oct 22, 2026 | 11.31 | 11.62 | 11.08 | 11.62 | 200625.0 |
| Oct 21, 2026 | 11.64 | 11.85 | 11.24 | 11.31 | 166827.0 |
| Oct 20, 2026 | 11.43 | 11.85 | 11.41 | 11.67 | 164922.0 |
| Oct 19, 2026 | 11.14 | 11.76 | 11.00 | 11.41 | 293410.0 |
| Oct 16, 2026 | 11.65 | 11.65 | 10.94 | 11.10 | 215413.0 |
| Oct 15, 2026 | 11.34 | 11.75 | 11.22 | 11.47 | 178426.0 |
| Oct 14, 2026 | 11.44 | 11.56 | 11.14 | 11.18 | 227615.0 |
| Oct 13, 2026 | 12.37 | 12.37 | 11.39 | 11.52 | 173991.0 |
| Oct 12, 2026 | 12.48 | 12.64 | 12.15 | 12.30 | 122895.0 |
| Oct 09, 2026 | 12.07 | 12.61 | 12.07 | 12.50 | 182070.0 |
| Oct 08, 2026 | 12.26 | 12.35 | 11.70 | 12.10 | 282901.0 |
| Oct 07, 2026 | 12.09 | 12.57 | 12.05 | 12.37 | 191667.0 |
| Oct 06, 2026 | 12.66 | 12.66 | 11.97 | 12.17 | 271697.0 |
| Oct 05, 2026 | 12.95 | 13.02 | 12.47 | 12.60 | 218875.0 |
| Oct 02, 2026 | 13.20 | 13.21 | 12.58 | 12.96 | 748004.0 |
| Oct 01, 2026 | 13.08 | 13.45 | 12.83 | 12.84 | 331488.0 |
| Sep 30, 2026 | 12.67 | 13.41 | 12.44 | 13.18 | 425884.0 |
| Sep 29, 2026 | 12.62 | 12.85 | 12.43 | 12.64 | 322821.0 |
| Sep 28, 2026 | 11.88 | 12.68 | 11.69 | 12.62 | 349328.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Perspective Therapeutics, Inc. | 1.15 |
| Vertex Pharmaceuticals, Inc. | 558.88 |
| Coherus Oncology, Inc. | 0.8301 |
| BridgeBio Pharma, Inc. | 74.95 |
| RenovoRx, Inc. | 1.33 |
Price Related Metrics
| PS Ratio | 4.442 |
| Price to Book Value | 3.086 |
| Earnings Yield | -22.51% |
| Market Cap | 311.88M |